[Bone morphogenetic proteins (BMP): clinical application for reconstruction of bone defects]

Area of Science:

• Biochemistry and Molecular Biology
• Regenerative Medicine
• Orthopedic Surgery

Context:

• Bone morphogenetic proteins (BMPs) are key regulators of bone and cartilage development.
• Recombinant BMPs (rhBMPs) show significant osteoinductive potential in vitro and in clinical settings.
• Current therapeutic applications often require systemic administration, potentially exceeding physiological doses.

Purpose:

• To review the multifaceted roles of BMPs in bone repair processes.
• To analyze the clinical applications and outcomes of BMP-based therapies.
• To discuss the advantages and disadvantages associated with BMP use in bone defect treatment.

Summary:

• BMPs are potent growth factors with angiogenic and osteogenic properties, essential for bone regeneration.
• rhBMPs have demonstrated efficacy in bone and cartilage formation, confirmed through in vitro and clinical studies.
• Systemic administration of rhBMPs can lead to adverse effects, including ectopic bone formation and increased morbidity in spinal fusion.

Impact:

• Advances understanding of BMPs in bone regeneration and tissue engineering.
• Highlights the potential for more predictable outcomes in bone repair using growth factor therapies.
• Informs future strategies for optimizing BMP delivery and minimizing side effects in clinical practice.